A recent NBC News article discussed Pfizer’s plans to submit data to the FDA for a fourth dose of its COVID-19 vaccine. As Pfizer CEO Albert Bourla put it to CNBC in an interview last Friday, “Clearly there is a need in an environment of omicron to boost the immune response.” Pfizer’s scientists are seeing that the initial booster’s protection against omicron is beginning to wane after three to four months, suggesting a need for a fourth dose.
Pfizer Nears Submitting Data to FDA for 4th COVID-19 Shot
Omicron-related cases are down significantly, but certain groups may still need additional vaccine protection.
Mar 17, 2022
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
